Onyx Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Onyx Pharmaceuticals Ownership

Who owns Onyx Pharmaceuticals?

Onyx Pharmaceuticals is owned by Amgen. It was acquired on August 25, 2013.

Onyx Pharmaceuticals Business Overview

Where is Onyx Pharmaceuticals headquartered?

Onyx Pharmaceuticals is headquartered in South San Francisco, California.

What sector is Onyx Pharmaceuticals in?

Onyx Pharmaceuticals is a life science company.

When was Onyx Pharmaceuticals founded?

Onyx Pharmaceuticals was founded in 1992.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 192 acquisitions of life science companies in 2013, including 26 acquisitions by private equity firms, and 166 by strategics.

Onyx Pharmaceuticals, Inc.

249 E. Grand Avenue,
South San Francisco, California 94080
United States,
(650) 266-0000
www.onyx-pharm.com

Onyx Pharmaceuticals, Inc. is engaged in the development of novel cancer therapies that target the molecular basis of cancer.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.